Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 5/20 | 0.39 |
| ▸ | REN | P00797 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29845974 | 0.84 | CTSD (0.41) | CTSD | |
| SCHEMBL31265320 | 0.84 | NPSR1 (0.38) | CTSD | |
| Gigiltvil SCHEMBL30741431 | 0.84 | CTSD (0.46) | CTSDREN | |
| SCHEMBL30050924 | 0.82 | CTSD (0.47) | CTSDREN | |
| SCHEMBL31462087 | 0.82 | BACE1 (0.42) | CTSD | |
| SCHEMBL31462106 | 0.82 | CTSB (0.42) | CTSD | |
| SCHEMBL30924772 | 0.81 | MME (0.47) | — | |
| SCHEMBL29448568 | 0.81 | TERT (0.39) | CTSD | |
| SCHEMBL30646300 | 0.81 | TERT (0.40) | CTSDREN | |
| SCHEMBL29387536 | 0.81 | MME (0.43) | CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559525-B2 | Conjugated fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy | ETH Zürich (CH) | 2026-02-24 | — | — | US | claimed |
| US-20230212228-A1 | Fibronectin-Binding Peptides for Use in Tumor or Fibrosis Diagnosis and Therapy | PAUL SCHERRER INSTITUT (CH) | 2023-07-06 | — | — | US | claimed |
| US-12559525-B2 | Conjugated fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy | ETH Zürich (CH) | 2026-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559525-B2 | Conjugated fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy | FN1, ASNS, FNIP1 | CTSD 4210/4885REN 3004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.